Barclays Maintains Philip Morris International(PM.US) With Buy Rating, Maintains Target Price $110

Barclays analyst Gaurav Jain maintains $Philip Morris International(PM.US)$ with a buy rating, and maintains the target price at $110.According to TipRanks data, the analyst has a success rate of 56.2

Futu NewsJul 3 19:33 · Ratings

FDA Efforts To Curb Flavored Vapes Said To Draw Supreme Court Review

FDA Efforts To Curb Flavored Vapes Said To Draw Supreme Court Review

BenzingaJul 2 21:32

Express News | Philip Morris: Unit Seeking to Expand Use to Additional Lawful Marketing Channels, Such as Point-of-Sale Display,Direct Mail to Age-Verified Consumers

BreakingsJul 2 04:06

Swedish Match Seeks FDA Renewal For Modified Risk Marketing Claim; Presents Real-World Evidence Supporting Reduced Harm And Population Health Benefits; Proposes Adjustments To Increase Switching From Smoking And Smokeless Tobacco; Experts Presented To...

Swedish Match Seeks FDA Renewal For Modified Risk Marketing Claim; Presents Real-World Evidence Supporting Reduced Harm And Population Health Benefits; Proposes Adjustments To Increase Switching From

BenzingaJul 2 04:06

Philip Morris (PM) Gains From Smoke-Free Focus, Key Priorities

Philip Morris International Inc. PM stands strong in the tobacco space due to its efforts to revolutionize products as per the evolving consumer patterns.

Yahoo FinanceJul 1 19:51

Swedish Match USA, Inc. Presents to U.S. Food and Drug Administration Advisory Committee to Renew Modified Risk Claim for General Snus

A pioneer in modified risk products, Swedish Match was the first company to receive a modified risk marketing claim and is the first to advance through the FDA renewal process Swedish Match presen

Philip MorrisJul 1 12:00